Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ Recombinant Mouse IL-28B/IFN-lambda 3 Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

$490.68

Specifications

Gene ID (Entrez) 338374
Molecular Weight (g/mol) 19.7 kDa
Name IL-28B/IFN-lambda 3
Quantity 25μg
Source E. coli-derived mouse IL-28B/IFN-lambda 3 protein Asp20-Val193,with an N-terminal Met
View More Specs

Products 2
Catalog Number Mfr. No. Formulation Price Quantity & Availability  
Catalog Number Mfr. No. Formulation Price Quantity & Availability  
1789ML025
View Documents
R&D Systems™
1789ML025
Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein.
Each for $490.68
Add to Cart
 
1789ML025CF
View Documents
R&D Systems™
1789ML025/CF
Lyophilized from a 0.2μm filtered solution in PBS.
Each for $490.68
Add to Cart
 
Description

Description

Measured in an anti-viral assay using HepG2 human hepatocellular carcinoma cells infected with encephalomyocarditis (EMC) virus. Sheppard, P. et al. (2003) Nat. Immunol. 4:63. The ED50 for this effect is 0.800-8.00 ng/mL.
Specifications

Specifications

338374
IL-28B/IFN-lambda 3
E. coli-derived mouse IL-28B/IFN-lambda 3 protein Asp20-Val193,with an N-terminal Met
Recombinant
19.7 kDa
25μg
Unconjugated
SDS
Documents

Documents

Product Certifications
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit